Printer Friendly
The Free Library
4,468,366 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Astro-Med Expects Flat Sales in Third Quarter.


WEST WARWICK, R.I.--(BUSINESS WIRE)--Oct. 7, 1997--Astro-Med, Inc. (NASDAQ:ALOT ALOT - Adaptive Large Optics Technologies
ALOT - Airborne Lightweight Optical Tracking
ALOT - Allotment
), stated today that it does not expect to achieve the $12.5 million forecast it made in August for the Third Quarter, which ends November 1, 1997.

Commenting on the announcement, Albert W. Ondis, CEO, stated: "Our sales managers here and abroad have made their forecasts, we have studied them carefully, and it looks as though we will come in with around $11.4 million in sales, up just slightly from last year's $11.1 million. Earnings will be down somewhat as a result of increased field sales staffing and other expenses. Domestically, we are making good gains. Sales of our Albert Grass Heritage and our CQL CQL - Continuous Query Language (Stream systems)-4 digital color printer are meeting forecasts. Export sales are down sharply from last year and the decline is in all sectors. Additionally, the strong dollar is contributing to the decline in export sales and has produced currency losses."

Mr. Ondis continued: "After taking these factors into consideration, we have reduced our Fourth Quarter forecast to approximately $12.0 million. Last year, we did $11.37 million.

"Net earnings may be lower as we continue to fund our selling strategy with increases in field sales personnel. We expect to finish the current fiscal year and begin the new year with very much stronger field sales organizations in place domestically and around the world."

Astro-Med, Inc. is a leading manufacturer of high tech specialty printing systems and electronic medical instrumentation employed around the world in a wide range of industrial, scientific, and medical applications.

CONTACT: Astro-Med, Inc.

Albert W. Ondis

Chief Executive Officer

Tel: 401-828-4000
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 7, 1997
Words:272
Previous Article:First Banks America Inc. and First Commercial Bancorp Inc. Announce Execution of Definitive Merger Agreement.
Next Article:Turner Awarded Construction Project to Renovate Historic Allen Theatre in Playhouse Square in Cleveland.
Topics:



Related Articles
Astro-Med reports third quarter results; Directors declare regular cash dividend and authorize 100,000 share stock buy-back.
Astro-Med reports second quarter results; Directors declard regular cash dividend.
Astro-Med receives FDA clearance to market Grass Digital EEG.
Astro-Med reports record first quarter sales.
Astro-Med Reports Second Quarter Results; Directors Declare Regular Cash Dividend.
Astro-Med Reports Third Quarter Results; Directors Declare Regular Cash Dividend.
Arrhythmia Research Technology Inc. Announces 1998 Fourth Quarter and Annual Results.
Strong Sales Growth for New Cancer Treatment Systems Prompts Varian Medical Systems to Raise Fiscal 2000 Earnings Estimates.
Arrhythmia Research Technology Inc. Announces Litigation Settlement.
E Med Future Sales Up 235 Percent for Third Quarter.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles